Australia markets closed

Esperion Therapeutics, Inc. (ESPR)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
1.8650+0.1150 (+6.57%)
As of 01:56PM EDT. Market open.
Currency in USD
Earnings estimateCurrent qtr. (Sep 2024)Next qtr. (Dec 2024)Current year (2024)Next year (2025)
No. of analysts6654
Avg. Estimate-0.17-0.05-0.180.25
Low estimate-0.22-0.22-0.45-0.36
High estimate-0.10.380.311.29
Year ago EPS-0.37-0.5-2.03-0.18
Revenue estimateCurrent qtr. (Sep 2024)Next qtr. (Dec 2024)Current year (2024)Next year (2025)
No. of analysts6565
Avg. Estimate53.52M62.82M348.3M423.85M
Low estimate43.4M52.1M307.1M271.8M
High estimate65.87M74.1M462.2M664.8M
Year ago salesN/A32.25M116.33M348.3M
Sales growth (year/est)N/A94.80%199.40%21.70%
Earnings history29/09/202330/12/202330/03/202429/06/2024
Est. EPS-0.43-0.480.05-0.18
Actual EPS-0.37-0.50.34-0.33
Difference0.06-0.020.29-0.15
Surprise %14.00%-4.20%580.00%-83.30%
EPS trendCurrent qtr. (Sep 2024)Next qtr. (Dec 2024)Current year (2024)Next year (2025)
Current estimate-0.17-0.05-0.180.25
7 days ago-0.16-0.05-0.180.22
30 days ago-0.15-0.11-0.19-0.03
60 days ago-0.11-0.070.010.02
90 days ago-0.09-0.09-0.040.01
EPS revisionsCurrent qtr. (Sep 2024)Next qtr. (Dec 2024)Current year (2024)Next year (2025)
Up last 7 daysN/AN/AN/AN/A
Up last 30 daysN/AN/AN/AN/A
Down last 7 daysN/AN/AN/AN/A
Down last 30 days1111
Growth estimatesESPRIndustrySector(s)S&P 500
Current qtr.54.10%N/AN/AN/A
Next qtr.90.00%N/AN/AN/A
Current year91.10%N/AN/AN/A
Next year238.90%N/AN/AN/A
Next 5 years (per annum)16.90%N/AN/AN/A
Past 5 years (per annum)N/AN/AN/AN/A